NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2025
CVR: 24257908
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057. The solvency ratio was 99.8%.
- Gross Profit
- DKK -52,056
- Profit/Loss
- DKK -44,180
- Equity
- DKK 24,891,057
- Total Assets
- DKK 24,939,927
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -52K | -44K | 24.9M | - |
| 2024 | - | -51K | -42K | 24.9M | - |
| 2023 | - | -41K | -4M | 25M | - |
| 2022 | - | -37K | -3M | 29M | 0 |
| 2021 | - | -32K | 637K | 29.5M | 0 |
Official annual report
How creditworthy is NOVOZYMES BIOINDUSTRIAL A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2024. Gross profit came to DKK -51,118, and the net result was DKK -41,700.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.